XRAY

11.90

2.22% -0.27

Vorhandelsmarkt: 11.97 0.07 +0.59%

Dentsply Sirona Inc (XRAY)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit Dividendenhistorie

Schlusskurs vom Vortag:

$12.17

Offen:

$12.19

24-Stunden-Volumen:

1.71M

Relative Volume:

0.39

Marktkapitalisierung:

$2.38B

Einnahmen:

$3.68B

Nettoeinkommen (Verlust:

$-598.00M

KGV:

-3.9698

EPS:

-2.9976

Netto-Cashflow:

$104.00M

1W Leistung:

-1.57%

1M Leistung:

+3.12%

6M Leistung:

-9.57%

1J Leistung:

-10.39%

1-Tages-Spanne:

$11.65

$12.28

1-Wochen-Bereich:

$11.65

$13.01

52-Wochen-Spanne:

$9.85

$17.18

Dentsply Sirona Inc Stock (XRAY) Company Profile

Firmenname

Dentsply Sirona Inc

Sektor

Healthcare (1111)

Branche

Medical Instruments & Supplies (58)

Telefon

844-546-3722

Adresse

13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE, NC

Mitarbeiter

14,000

Twitter

@DentsplySirona

Nächster Verdiensttermin

2026-05-14

Neueste SEC-Einreichungen

XRAY's Discussions on Twitter

Compare XRAY vs ISRG, BDX, MDLN, ALC, RMD

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
XRAY Dentsply Sirona Inc	11.90	2.46B	3.68B	-598.00M	104.00M	-2.9976
ISRG Intuitive Surgical Inc	478.82	160.28B	10.58B	3.00B	2.83B	8.2437
BDX Becton Dickinson Co	154.85	44.57B	21.92B	1.76B	2.63B	6.1223
MDLN Medline Inc	46.23	38.56B	28.43B	1.16B	1.26B	1.4457
ALC Alcon Inc	75.86	37.93B	10.40B	980.00M	1.61B	1.9749
RMD Resmed Inc	219.51	32.23B	5.40B	1.49B	1.78B	10.12

Dentsply Sirona Inc Stock (XRAY) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2026-04-15	Eingeleitet	Citigroup	Sell
2026-02-19	Hochstufung	BofA Securities	Neutral → Buy
2025-12-09	Eingeleitet	Barclays	Underweight
2025-11-07	Herabstufung	William Blair	Outperform → Mkt Perform
2025-04-15	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2025-03-13	Herabstufung	Needham	Buy → Hold
2025-02-14	Eingeleitet	Wells Fargo	Equal Weight
2025-01-23	Herabstufung	Jefferies	Buy → Hold
2025-01-07	Herabstufung	Evercore ISI	Outperform → In-line
2024-12-04	Eingeleitet	Mizuho	Neutral
2024-11-07	Herabstufung	Leerink Partners	Outperform → Market Perform
2024-10-25	Bestätigt	Needham	Buy
2024-08-20	Bestätigt	Needham	Buy
2024-02-26	Eingeleitet	Leerink Partners	Outperform
2023-11-16	Eingeleitet	Needham	Buy
2023-11-10	Hochstufung	William Blair	Mkt Perform → Outperform
2023-01-12	Hochstufung	William Blair	Underperform → Mkt Perform
2022-08-05	Herabstufung	William Blair	Mkt Perform → Underperform
2022-06-02	Hochstufung	UBS	Neutral → Buy
2022-04-20	Herabstufung	Piper Sandler	Overweight → Neutral
2022-04-20	Herabstufung	William Blair	Outperform → Mkt Perform
2022-04-19	Herabstufung	BofA Securities	Buy → Neutral
2022-04-19	Herabstufung	Robert W. Baird	Outperform → Neutral
2022-01-31	Eingeleitet	Morgan Stanley	Overweight
2021-10-01	Fortgesetzt	Credit Suisse	Outperform
2021-08-09	Bestätigt	H.C. Wainwright	Neutral
2021-08-06	Bestätigt	Barrington Research	Outperform
2021-08-05	Fortgesetzt	Credit Suisse	Outperform
2021-03-02	Hochstufung	Barrington Research	Mkt Perform → Outperform
2021-03-02	Bestätigt	H.C. Wainwright	Neutral
2021-01-05	Bestätigt	H.C. Wainwright	Neutral
2020-12-18	Herabstufung	Stifel	Buy → Hold
2020-11-17	Herabstufung	Barclays	Equal Weight → Underweight
2020-11-09	Bestätigt	H.C. Wainwright	Neutral
2020-10-22	Hochstufung	Guggenheim	Neutral → Buy
2020-08-10	Bestätigt	H.C. Wainwright	Neutral
2020-06-16	Eingeleitet	Piper Sandler	Overweight
2020-06-15	Bestätigt	H.C. Wainwright	Neutral
2020-05-27	Hochstufung	Evercore ISI	In-line → Outperform
2020-05-11	Herabstufung	Barrington Research	Outperform → Mkt Perform
2020-04-24	Bestätigt	H.C. Wainwright	Neutral
2020-04-08	Hochstufung	Robert W. Baird	Neutral → Outperform
2020-04-07	Herabstufung	Goldman	Buy → Neutral
2020-04-02	Hochstufung	Wolfe Research	Peer Perform → Outperform
2020-03-03	Bestätigt	H.C. Wainwright	Neutral
2020-02-19	Bestätigt	Stifel	Buy
2019-12-11	Herabstufung	JP Morgan	Overweight → Neutral
2019-08-02	Hochstufung	Wellington Shields	Hold → Gradually Accumulate
2019-07-26	Eingeleitet	Evercore ISI	In-line
2019-07-09	Bestätigt	H.C. Wainwright	Neutral
2019-05-30	Eingeleitet	Wolfe Research	Peer Perform

Alle ansehen

Dentsply Sirona Inc Aktie (XRAY) Neueste Nachrichten

Apr 23, 2026

DENTSPLY SIRONA : 2025 Annual Report - marketscreener.com

Apr 23, 2026

[ARS] DENTSPLY SIRONA Inc. SEC Filing - Stock Titan

Apr 23, 2026

15M-share incentive plan boost on Dentsply Sirona (NASDAQ: XRAY) 2026 ballot - Stock Titan

Apr 23, 2026

Dental Hand Instrument Market Is Booming So Rapidly | Dentsply Sirona, Henry Schein Inc, HuFriedy Mfg. Co LLC, 3M - openPR.com

Apr 23, 2026

Apr 22, 2026

Dentsply Sirona to Host First Quarter 2026 Conference Call on May 5 - Yahoo Finance

Apr 22, 2026

Apr 21, 2026

Dentsply Sirona Inc stock (US24906P1093): Why does its dental tech leadership matter more now for st - AD HOC NEWS

Apr 21, 2026

Apr 20, 2026

Dentsply Sirona Inc stock (US24906P1093): Is its dental equipment dominance still the key to steady - AD HOC NEWS

Apr 20, 2026

Apr 19, 2026

Reasons to retain DENTSPLY SIRONA stock in your portfolio now - MSN

Apr 19, 2026

Evaluating Dentsply Sirona (XRAY) After Recent Share Price Rebound And Deep Discount To Estimated Fair Value - Sahm

Apr 19, 2026

Apr 18, 2026

XRAY & Siemens Healthineers secure FDA nod for dental-dedicated MRI - MSN

Apr 18, 2026

Bruker, Amneal, Amphastar Pharmaceuticals, Dentsply Sirona, and PacBio Stocks Trade Up, What You Need To Know - Yahoo Finance

Apr 18, 2026

Apr 17, 2026

DENTSPLY SIRONA (NASDAQ:XRAY) Rating Increased to Strong Sell at Citigroup - MarketBeat

Apr 17, 2026

Dentsply Sirona Inc stock (US9839191015): Is its consumables dominance strong enough to unlock new u - AD HOC NEWS

Apr 17, 2026

Conical Dental Implant Market 2026-2033: Growth Overview, - openPR.com

Apr 17, 2026

Apr 16, 2026

Citi Maintains Dentsply Sirona(XRAY.US) With Sell Rating, Maintains Target Price $10 - Moomoo

Apr 16, 2026

Great Hill Capital LLC Boosts Stake in DENTSPLY SIRONA - National Today

Apr 16, 2026

DENTSPLY SIRONA (XRAY) Stock: Price vs Value (In Focus) 2026-04-16Price Target - Xã Thanh Hà

Apr 16, 2026

Great Hill Capital LLC Takes $8.27 Million Position in DENTSPLY SIRONA Inc. $XRAY - MarketBeat

Apr 16, 2026

Citigroup initiates coverage of DENTSPLY SIRONA (XRAY) with sell recommendation - MSN

Apr 16, 2026

XRAY Initiated Coverage by Citigroup -- Rating Set to Sell - GuruFocus

Apr 16, 2026

Apr 15, 2026

XRAY Director Acquires 2,638 Phantom Stock Shares April 15, 2026 - Meyka

Apr 15, 2026

Apr 14, 2026

Dentsply Sirona Inc stock (US24906P1093): Why does its dental consumables dominance matter more now? - AD HOC NEWS

Apr 14, 2026

Apr 13, 2026

Dentsply Sirona’s Implant Solutions World Summit 2026 unveils scientific programme and masterclasses - Dental Tribune US

Apr 13, 2026

$13+ Bn Dental Laboratories MarketGlobal Forecast to - GlobeNewswire

Apr 13, 2026

Apr 10, 2026

Dentsply Sirona Inc stock (US24906P1093): Is consumables strength enough to drive steady U.S. invest - AD HOC NEWS

Apr 10, 2026

Is DENTSPLY SIRONA (XRAY) Stock Consolidating | Price at $11.79, Down 0.59%Viral Momentum Stocks - Cổng thông tin điện tử Tỉnh Sơn La

Apr 10, 2026

Apr 09, 2026

SG Americas Securities LLC Invests in DENTSPLY SIRONA - National Today

Apr 09, 2026

SG Americas Securities LLC Makes New Investment in DENTSPLY SIRONA Inc. $XRAY - MarketBeat

Apr 09, 2026

DENTSPLY SIRONA: Another Episode Of An Anticipated Recovery (NASDAQ:XRAY) - Seeking Alpha

Apr 09, 2026

Handpieces Market Size Surging at 6.5% CAGR | Major Players: Kavo, NSK, Dentsply Sirona, W&H, Bien Air - openPR.com

Apr 09, 2026

Apr 08, 2026

Evercore Maintains Dentsply Sirona(XRAY.US) With Hold Rating, Cuts Target Price to $13 - Moomoo

Apr 08, 2026

Analyst Calls: What is the dividend yield of DENTSPLY SIRONA IncEntry Point & Short-Term Trading Alerts - baoquankhu1.vn

Apr 08, 2026

Growth Report: Is DENTSPLY SIRONA Inc in a long term uptrend2026 Big Picture & Daily Entry Point Trade Alerts - baoquankhu1.vn

Apr 08, 2026

Apr 07, 2026